Logo von


About Eucodis

EUCODIS Bioscience

EUCODIS Bioscience delivers high-performance enzyme solutions for applications in pharma, biotech, fine chemicals, food & feed, and cosmetics industries. With a portfolio of over 50 enzymes including innovative lipases, beta-lactamases, peroxidases and other enzymes EUCODIS Bioscience has a proven track record of providing customized solutions. As an application-driven provider of tailored enzyme solutions, we work closely with our customers to better understand and fulfill their individual biocatalyst needs.

EUCODIS Bioscience is an expert in engineering and developing enzymes for industrial applications, using our proprietary in vivo recombination technology – either alone or in combination with other mutagenesis technologies – to modulate activities of target enzymes in accordance with required specifications. Coupled with high-throughput screening capabilities and assay platforms, we can deliver optimized enzymes with desired properties within agreed timelines.

Our contract manufacturing capabilities for recombinant protein and enzyme production cover the whole spectrum of custom protein & enzyme services like protein & enzyme engineering, strain & bioprocess development, fermentation in various pro- and eukaryotic host expression systems, DSP & protein purification and routine industrial protein manufacturing. EUCODIS Bioscience is specialized in setting up optimized bioprocesses for the scale-up and manufacture of recombinant proteins under ISO 9001:2015 to assure maximum yields, stability and desired purity in reproducible and reliable quality.

EUCODIS Bioscience was founded in 2007 and is headquartered in Vienna, Austria.


Company Profile

Download our Company Profile here >


The EUCODIS Bioscience Management Team

Our management has extensive experience in the biotechnology and pharma industry with special expertise in industrial enzyme development and marketing. With both scientific and business related backgrounds our team can find customized solutions in order to fulfill our customers’ needs.

Patrik Cesky, MA
Managing Director

Patrik Cesky was appointed as Managing Director in 2018 after being responsible for EUCODIS Bioscience as an Investment Manager with ARAX Capital Partners since 2014.

He has accumulated around 10 years of professional experience in the Venture Capital industry, general management and corporate law. His areas of focus comprise Corporate Governance & Finance, Strategic Management and M&A. Patrik holds a BA in Business Administration from IMC Krems University of Applied Sciences and a MA in Financial Management from FH Wien der WKW.

Dr. Jan Modregger, MBA
Head of Research & Development, Production

Jan Modregger was appointed as Head of Research and Development in 2011 after serving EUCODIS Bioscience as project head for various enzyme development projects since 2008.

Before joining EUCODIS Bioscience, he worked as research group leader in the pharmaceutical biotech industry responsible for several development projects involving anti-inflammatory diseases.

Jan Modregger holds a PhD in Physiological Chemistry from the University of Cologne, Germany and worked as a research associate at the Howard Hughes Medical Institute at Yale University, New Haven. In 2010, he received a fellowship for the executive MBA program of the Institute for Management, Salzburg, and the University of Klagenfurt, which he completed successfully in 2013.

Mag. Michael Zimmel
Head of Finance & Administration

Michael Zimmel was appointed as Head of Finance & Administration in 2017 after supporting EUCODIS Bioscience as Finance Specialist since 2015.

As Head of Finance & Administration he is providing EUCODIS Bioscience with more than 15 years of experience in finance management with a specific emphasis on financial and business controlling, funding of investment projects (including subsidies/grants), purchasing, accounting and taxes as well as auditing. He worked in several sectors with unique requirements like the pharmaceutical, energy, agrochemical, functional food- and biotech industry.

Michael Zimmel holds a Master degree in Business Administration from the Vienna University of Economics and Business, Austria.

Karim Vadiwala, PhD
Business Development & SALES MANAGER

Karim Vadiwala was appointed as Business Development and Sales Manager in February 2021.

He has finished Social Intrapreneurship for Innovation in Health course by Boehringer Ingelheim and Ashoka. He has also undertaken ‘From Scientist to Entrepreneur’ course by INiTS, Vienna’s High-Tech Incubator, and Leadership Management course by hfp consulting, Germany. He also has business experience in life science and digital start-ups.

Karim Vadiwala holds a PhD in Molecular Biology from the University of Vienna and Masters in Prenatal Genetics and Fetal Medicine from University College London (UCL), London.

Karim Vadiwala is responsible for all sales and business development related activities for international customers.

Janna Frömbling, MSc
Business Development & SALES MANAGER

Janna Frömbling was appointed as Business Development and Sales Manager in 2021 after supporting EUCODIS as a Sales Associate in the past.

During her occupation at the University for Veterinary Medicine of Vienna she fostered her background in microbiology, proteomics and metabolomics. In the postion as a Sales Consultant she developed expertise in customer services and acqusition. At EUCODIS Janna Frömbling is responsible for sales, business partnering in the DACH region and marketing.

Janna Frömbling holds a MSc degree in Bioscience from the University of Münster, Germany.

Quality Management

At EUCODIS Bioscience we follow a strict quality policy which reflects the principles of the quality management system according to ISO9001:2015.

Since our customers are our highest priority, we aim to understand their requirements and surpass their expectations. We commit ourselves to best efforts to achieve our customers’ trust and confidence in our skills and strengths of tailored solutions and products to build up long-term and sustainable relationships.

We recognize ISO9001:2015 as the fundamental Quality Management system in all departments of EUCODIS Bioscience, and monitor, plan and implement all measures relevant for such product quality and safety. This includes defining requirements and actions, monitoring development, production and quality control as well as considering risks and opportunities, up to managing and communicating product and process relevant changes.


Our QM Manual is available on request. Please contact
office(at)eucodis.com  >

Business Development


We are interested in

  • Co-developing novel enzyme solutions with academic and industrial partners
  • Out-licensing of our CTAT technology for bioconjugation of proteins/antibodies
  • Purchasing or in-licensing of selected enzymes
  • Technologies for enzyme or protein development and production that complement our core competences, both from academic institutions as well as from the industry.

We are also offering co-marketing opportunities of enzymes or technologies through our experienced marketing and sales team.


For more information or to submit your inquiry please contact us at
sales(at)eucodis.com  >


EUCODIS has an extensive network of consultants and partners to expand and complement our capabilities and offers a highly competitive service and product portfolio to our customers.

Our partners include:


EUCODIS Bioscience is a private company, backed up by institutional venture capital investors, founders, and private investors.

Investors in the Company include:

The ARAX Capital Partners GmbH is specialized in the financing of young, Austrian technology and life science companies supporting them with strategic knowhow in their development.

Equity One is a management company based in Vienna administrating shares for private investors.

GCP Gamma Capital Partners is a private Venture Capital investment and Equity consulting firm focusing on dynamic technology and growth companies in Austria, Germany, Switzerland and CEE countries bordering Austria.

The IBG Beteiligungsgesellschaft Sachsen-Anhalt mbH is a central funding institution of Sachsen-Anhalt in Germany investing in small and medium sized technology companies.

Additionally, the Company has received significant support by the following Austrian and German public agencies:


Our employees are constantly given the opportunity of meeting new and intriguing challenges in order to find innovative solutions to our customers’ requests, which are as varied as the application fields of our enzymes.

Open positions:

  • Currently, there are no open positions available. 

(Eucodis Bioscience is using your personal data exclusively for business-relevant communication. We ensure that all your personal data are not passed onto third parties. If you have any questions please do not hesitate to contact us via email at office(at)eucodis.com.)


If you are interested in becoming a member of our team, we are always glad to receive your CV and unsolicited application via
jobs(at)eucodis.com  >
Or our application form